The PE Ratio as of September 2024 (TTM) for Alzamend Neuro, Inc. (ALZN) is -0.01

According to Alzamend Neuro, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.35% compared to the average of -1.54 of the last 4 quarters.

Alzamend Neuro, Inc. (ALZN) Historical PE Ratio (quarterly & annually)

How has ALZN PE Ratio performed in the past?

The mean historical PE Ratio of Alzamend Neuro, Inc. over the last ten years is -764.00. The current -0.01 PE Ratio has changed -99.87% with respect to the historical average. Over the past ten years (40 quarters), ALZN's PE Ratio was at its highest in in the January 2001 quarter at 0. The PE Ratio was at its lowest in in the October 2017 quarter at -797.89.

Alzamend Neuro, Inc. (ALZN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alzamend Neuro, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alzamend Neuro, Inc. (ALZN) Average PE Ratio

How has ALZN PE Ratio performed in the past?

The current PE Ratio of Alzamend Neuro, Inc. (ALZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alzamend Neuro, Inc. (ALZN) PE Ratio vs. Peers

How is ALZN’s PE Ratio compared to its peers?

Alzamend Neuro, Inc.’s PE Ratio is less than TRACON Pharmaceuticals, Inc. (0.03), greater than Solid Biosciences Inc. (-3.66), greater than Kezar Life Sciences, Inc. (-0.41), greater than Senti Biosciences, Inc. (-0.23), less than X4 Pharmaceuticals, Inc. (0), less than Inozyme Pharma, Inc. (7.41), greater than Terns Pharmaceuticals, Inc. (-3.48), greater than Day One Biopharmaceuticals, Inc. (-6.06), greater than HOOKIPA Pharma Inc. (-7.39), greater than Acumen Pharmaceuticals, Inc. (-1.22), greater than VectivBio Holding AG (-2.06), greater than Molecular Partners AG (-7.94), greater than Adverum Biotechnologies, Inc. (-2.67), greater than Alector, Inc. (-1.41), greater than Adagene Inc. (-2.92), greater than null (-2.86),

Build a custom stock screener for Alzamend Neuro, Inc. (ALZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alzamend Neuro, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alzamend Neuro, Inc. (ALZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alzamend Neuro, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.